[Determination of methylnicotinamide in the blood and urine as a means of controlling neuroleptic treatment effectiveness].
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000378:metabolism; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000032:analysis; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism
D014150:Antipsychotic Agents; D009536:Niacinamide; C008472:N-methylnicotinamide
Opredelenie metilnikotinamia v krovi i moche kak sposob kontrolia za éffektivnost'iu lecheniia neĭroleptikami.